# Acceptability and GI Tolerance of an Alpha-lactalbumin-enriched Formula

> **NCT02431377** · NA · COMPLETED · sponsor: **Société des Produits Nestlé (SPN)** · enrollment: 40 (actual)

## Conditions studied

- Infant Formula Intolerance

## Interventions

- **OTHER:** S-26 Gold

## Key facts

- **NCT ID:** NCT02431377
- **Lead sponsor:** Société des Produits Nestlé (SPN)
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2015-09
- **Final completion:** 2015-10
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2015-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02431377

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02431377, "Acceptability and GI Tolerance of an Alpha-lactalbumin-enriched Formula". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02431377. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*